Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

People who take Novo Nordisk's semaglutide-based injectables Ozempic and Wegovy seem to be way less likely to die from ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

Appetite suppressants: These pills work by reducing hunger and making you feel full longer. By curbing appetite, suppressants ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

The most advanced of these pills include a form of semaglutide, the active ingredient in Ozempic and Wegovy, being developed by Novo Nordisk. The Danish drugmaker reported last year that a late ...

17. Semaglutide, the active ingredient in Ozempic, is being developed in pill form by Novo Nordisk and has shown promising results, with study participants losing an average of 15% of their body ...